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Background: In evaluating complex interventions, it is a 
challenge for researchers to provide transparent reporting 
of the intervention content with sufficient detail and clarity 
such that effects can be compared across studies or coun-
tries. 
Objective: To describe and compare the content of cur-
rent rehabilitation for patients with inflammatory arthritis 
across 4 northern European countries. 
Patients and methods: A total of 731 patients with inflam-
matory rheumatic diseases participated in a multicentre, 
longitudinal observational study carried out in Sweden, The 
Netherlands, Denmark and Norway. Data on context, struc-
ture and process were reported by patients and teams at the 
different participating study sites according to the Scandina-
vian Team Arthritis Register – European Team Intiative for 
Care Research (STAR-ETIC) framework. 
Results: Although large similarities were found in the con-
text, there were important differences between the Nether-
lands and the Scandinavian countries. Regarding structure, 
there were considerable differences in the length of the re-
habilitation period across settings and countries. The most 
evident differences concerned process variables, especially 
the type and dosage of individual treatment modalities. 
Conclusion: The variation in important aspects of arthritis 
rehabilitation found in the present study underline the need 
for transparent and standardized description of these varia-
bles when comparing effects across settings and countries. A 
standardized description of current practice can be achieved 
by the STAR-ETIC framework.
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INTRODUCTION
Despite improvements in pharmacological and surgical treat-
ment for patients with arthritis, non-pharmacological treatment 
in terms of arthritis rehabilitation is still often required (1, 2). 
Arthritis rehabilitation is a complex, multidisciplinary treat-
ment approach defined as “a group of health professionals from 
various disciplines who work together towards a common goal” 
(2). This type of healthcare service can take place in various 
clinical settings; as inpatient and outpatient programmes at 
rheumatology hospital departments, and at specialized reha-
bilitation centres, mostly as inpatient programmes. In recent 
years, there has been increased use of outpatient programmes 
in arthritis rehabilitation (3, 4). 
Both pharmacological and non-pharmacological care, 
provided by single professions or teams, should be based 
on evidence from best available research into the healthcare 
service that is provided. A common challenge for clinicians 
and researchers who want to evaluate arthritis rehabilitation 
in clinical trials, routine quality management and/or registry 
systems, is to provide transparent reporting of the intervention 
content with sufficient detail and clarity such that the study 
can be compared with other studies or replicated by others. 
The difficulties in reporting all necessary details of complex 
interventions, such as arthritis rehabilitation, is one of the 
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reasons why it is challenging for researchers to synthesize data 
and systematically review such interventions (5, 6).
The lack of consensus regarding how to describe the con-
tent of non-pharmacological interventions in trials and other 
studies stands in sharp contrast to the last years’ achievement 
in consensus regarding how healthcare interventions should 
be evaluated. The Outcome Measures in Rheumatology rec-
ommendations (7) on evaluating patients’ health status and 
the Consolidated standards of Reporting Trials (CONsORT) 
recommendations (8, 9) on guiding clinical studies represent 
large steps forward with respect to international consensus on 
crucial aspects of healthcare evaluations. The lack of detailed 
guidance with respect to describing the content of interven-
tions, however, was one of the reasons why the Transparent 
Reporting of Evaluations with Non-randomized Designs 
(TREND) statement was developed (10). The TREND guide-
lines emphasize the report of theories used and descriptions 
of behavioural and public health interventions. This topic has 
also been emphasized by research groups within arthritis, for 
example a framework for reporting health service models for 
managing rheumatoid arthritis (RA) has been published (11), 
and a quality measure of the process of care in RA has been 
developed (12). Another initiative in this area is the scandi-
navian Team Arthritis Register – European Team Intiative for 
Care Research (sTAR-ETIC) collaboration. On the basis of 
a systematic literature search and Delphi consensus rounds 
within a group of clinicians, researchers and patients in the 
Netherlands, sweden, Denmark and Norway, a framework to 
describe the context, structure, process and outcome of arthritis 
team rehabilitation have been suggested (13). The overarch-
ing component of context describes the national welfare and 
healthcare systems, whereas structure describes core elements 
at institutional level, process describes details of the rehabili-
tation provided at an individual level, and outcome suggests 
domains for evaluation in arthritis rehabilitation (13). 
The objective of this study was to describe and compare the 
content of arthritis rehabilitation for patients with inflammatory 
arthritis across 4 northern European countries. 
MATERIAl AND METhODs
The sTAR-ETIC (www.star-etic.se) is an international collaboration 
between multidisciplinary researchers, clinicians and patient repre-
sentatives with expertise in the field of arthritis rehabilitation. The 
overall aim of the sTAR-ETIC project was to study the structure, 
process and outcome of arthritis rehabilitation of rheumatic diseases, 
and to create a common database. 
The present article presents results on the context, structure and 
process of arthritis rehabilitation, while the outcomes are presented in 
the accompanying article. Data were available from two sources: (i) 
patient-reported data from a multicentre, longitudinal observational 
study carried out in sweden, the Netherlands, Denmark and Norway; 
and (ii) additional data on context, structure and process provided by 
the teams at the different participating study sites.
Design 
This was a multicentre, longitudinal observational study in which rheu-
matology hospital departments and specialized rehabilitation centres that 
provided rehabilitation for patients with inflammatory arthritis partici-
pated. Eligible patients at the participating centres were consecutively 
recruited in the period from 2006/2007 to 2009. Data was registered in the 
sTAR-ETIC register, which included 1,449 patients by september 2010.
Each of the teams at the different healthcare sites was asked to 
complete information in the sTAR-ETIC checklist on behalf of the 
arthritis rehabilitation provided at their site. A research coordinator in 
each of the countries was responsible for administrating this checklist. 
Patients and study sites
Inclusion criteria were patients aged 18 years or more who were sched-
uled for a rehabilitation period of at least one week duration and with an 
inflammatory joint disease (RA and spondyloarthritis (SpA); including 
ankylosing spondylitis, undifferentiated spondylarthritis and psoriatic 
arthritis). Patients’ diagnosis was confirmed by a rheumatologist at 
each site. Exclusion criteria were severe psychiatric comorbidity or 
inability to communicate in written swedish/Dutch/Danish/Norwegian. 
In Norway, patients > 75 years were also excluded. The study was 
approved by the regional committee for medical research ethics in 
each of the 4 countries.
In Denmark, the king Christian x’s hospital, University of southern 
Denmark participated and included a total of 115 patients with inflam-
matory joint disease (94 patients with RA and 21 with spA). Complete 
data from Denmark for the current study was provided for 91 patients.
In the Netherlands, the Department of Rheumatology, leiden 
University Medical Center, participated and included a total of 81 
patients with inflammatory joint disease (49 patients with RA and 32 
with spA). Complete data from the Netherlands for the current study 
was provided for 80 patients.
In Norway, a total of 4 rheumatology hospital departments and 9 
rehabilitation centres participated and included eligible patients with 
various rheumatic diseases referred to a rehabilitation stay during a 
3-month recruitment period at the end of 2006. In the current study, 
including only patients with inflammatory joint disease, the patients were 
recruited from the 4 rheumatology hospital departments and 6 rehabilita-
tion centres. The hospital departments were the NRRE, Diakonhjemmet 
hospital, Oslo, Martina hansen hospital, Bærum/Oslo, lillehammer 
Rheumatological hospital, lillehammer, and Østfold hospital, sarps-
borg. The rehabilitation centres were Borger Bad Rehabilitation Center, 
Jeløya Rehabilitation Center, skogli Rehabilitation Center, Tonsåsen 
Rehabilitation Center, Valnesfjord Rehabilitation Center, and Vikersund 
Kurbad. A total of 157 patients had an inflammatory joint disease (73 
patients with RA and 84 patients with spA). Complete data from Norway 
for the current study was provided for 149 patients.
In sweden 3 rheumatology departments participated; the spenshult 
hospital for Rheumatic Diseases and the Clinics of Rheumatology in 
lund and Malmö, skane University hospital. They included a total 
of 494 with inflammatory joint disease (282 patients with RA and 212 
patients with spA). Complete data from sweden for the current study 
was provided for 411 patients.
Measurement of sociodemographic and health characteristics 
At admission, physicians examined the patients and provided diagnos-
tic information. The patients completed a comprehensive questionnaire 
at admission and discharge. The baseline questionnaire included socio-
demographic and health status variables. sociodemographic variables 
concerned age, gender, marital status (married/co-habitant or living 
alone), and work status (employed or not). 
health status variables included primary diagnosis (RA, spA, psori-
atic arthritis (psA)), comorbidity (presence of other diseases based on 
a list of 12 possible diagnostic groups), use of medication (biologics, 
disease-modifying anti-rheumatic drug (DMARDs), corticosteroids, 
and pain medication), and functional status assessed by the health 
Assessment Questionnaire) (14). 
Arthritis rehabilitation
Checklist for context, structure and process. Based on the sTAR-ETIC 
framework (13) we developed a checklist of information to include 
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when reporting arthritis rehabilitation or other non-pharmacological 
interventions. The definitions for each of the items within the con-
text, structure and process components of the framework (13) were 
standardized into a checklist containing a total of 18 items; 1 for the 
context, 9 for structure, and 8 for process (Table I). 
Rehabilitation diary. During the rehabilitation period the patients 
provided information regarding the type and frequency of various 
treatment modalities in a rehabilitation diary. The original rehabilita-
tion diary was developed in two expert groups, first in Norway and 
second in the sTAR-ETIC project group (13, 15). 
Table I. The Scandinavian Team Arthritis Register – The European Team Initiative of Care research (STAR-ETIC) checklist of information to include 
when reporting studies of arthritis rehabilitation care in arthritis
Items Description of reporting
Context 
1. Welfare and healthcare systems Description of the national healthcare and welfare systems in which the arthritis rehabilitation finds place 
Structure
2. Funding Description of funding/reimbursement of the rehabilitation service
3. Criteria for admission/discharge Description of criteria for admission and discharge 
4. Clinical setting Description of level of care (primary/secondary/other), type of setting (inpatient/outpatient, rehabilitation 
centre/general hospital), and primary diagnosis (secondary diagnosis if relevant) 
5. Rehabilitation team 5a. specify type and number of each professions (medical doctor/specialist, physiotherapist, occupational 
therapist, nurse, psychologist, social worker, nutritionist, other) in the team 
5b. specify communication form, e.g. informal communication every day and/or frequency of formal team 
meetings
6. Rehabilitation management Brief description of the rehabilitation plan provided. specify if a particular tool was used, e.g. the ICF-based 
”Rehab-Cycle” 
7. patient involvement Description of how patient was involved in treatment decisions and plan. provide number of organized 
meetings between the team and the patient 
8. Family involvement Description of how patient’s family was involved in treatment decisions and plan
9. length of team care specify number of active rehabilitation days for the whole team care period
10. Follow-up Description of how patient was followed up after discharge from the rehabilitation period (e.g. continuing 
management in primary care or other follow-up management) NB. Administration of self-reported 
questionnaires is not considered as a structural procedure for follow-up.
Process 
11. Goals Specify whether treatment goals were defined or not and how they were developed (patient self-report tool, 
patient interview, organized goal setting meeting with team members etc). If needed, specify goals classified 
according to the ICF components (frequency of BF, Bs, Al, pR)
12. Assessment and evaluations Describe the standardized assessment and evaluation at admission/discharge, e.g. according to the ICF 
components
13. Interventions 13a. specify frequency of individual treatment sessions for each health profession in the team (medical 
doctor/specialist, physiotherapist, occupational therapist, nurse, psychologist, social worker, nutritionist, 
other), and provide estimates of average duration per session (if available).
Based on this information, give the total number of individual treatment sessions for the whole 
rehabilitation period, mean duration per session 
13b. specify frequency of group education and group exercise sessions for the whole rehabilitation period, 
and provide estimates of mean duration per session 
13c. specify type of individual treatment modalities that are available: 
1) Individual patient education/information/counsellinga 
2) Individual exercises (e.g. mobility, muscle strength, coordination, aerobic capacity, relaxation, ADl, 
other individual exercises)
3) Electrotherapy (e.g. ultrasound, TENs, low-level laser therapy, short-wave therapy and pulsed 
electromagnetic energy, shock wave therapy)
4) Thermotherapy (e.g. heat and/or cold packs)
5) Acupuncture
6) “Hands-on” intervention (e.g. massage, passive joint mobility/manipulation, stretching, acupressure/
trigger-point treatment, other soft tissue techniques)
7) psychological consultation 
8) ADl help (e.g. help with activities of daily living from nurse)
9) Other (specify)
For each treatment modality that is available specify for how large proportion of the patients this is used in 
the following categories: 0–25%; 26–50%; 51–75%; 76–100%; all
13d. specify frequency of self-training for the whole rehabilitation period 
13e. specify frequency of formal interdisciplinary team meetings 
aIf necessary, topics can be specified according to the following list: pain, physical activity, coping, weight control/nutrition, joint protection, assistive 
tools, Activities of Daily Living (ADL), social network, leisure activities, economy, official services, home visit, work/education, individual plan, other 
consultations, contact family/relatives, contact official services, contact healthcare providers, external collaboration meeting, other external meetings.
ICF: International Classification of Functioning, Disability and Health; BF; Body Function; BS: Body Structure; AL: Activity Limitation; PR: 
participation Restrictions; TENs: transcutaneous electrical nerve stimulation.
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Statistical analysis
Descriptive statistics were calculated for each of the countries and 
study sites. Continuous variables are presented by means with standard 
deviations (sDs) and categorical variables are presented by frequencies 
and percentages. Differences between the countries/sites were analysed 
using analysis of variance analysis. spss version 14.0 was used for the 
statistical analysis. The level of statistical significance was set at 5%. 
string/text variables were analysed by a simple qualitative analysis of 
similarities and differences across the countries/sites.
REsUlTs
Patients
A total of 839 patients had a diagnosis of inflammatory joint 
disease (RA and spA) and completed a period of arthritis 
rehabilitation. Of these patients, 93 were excluded due to 
incomplete data at baseline or discharge, 14 had a second 
episode of rehabilitation, and 1 had a rehabilitation length of 
less than 1 week, leaving 731 (86.3%) available for the present 
study. Analyses of possible differences between the study 
group (n = 731) and those who could not be included (n = 108) 
showed that there were no statistical significant differences in 
any of the sociodemographic and health characteristics except 
for age and work status. The patients who were not included 
in the material were significantly older (mean age 62 vs 54 
years) and were more likely to be unemployed. 
The patients had a mean age of 54.3 years sD 13.5 years) 
and there were more women (67%) than men (33%). Approxi-
mately one-third (35%) were employed. DMARDs (56%) was 
the most commonly used medication, followed by analgesics 
(47%), corticosteroids (25%) and biologics (21%). Many 
patients (82%) reported comorbidities. Table II shows the 
variation in baseline characteristics of the included patients 
across the 4 countries. 
Context and structure of arthritis rehabilitation
The context across the 3 scandinavian countries was rather 
similar as they all have public welfare and healthcare systems, 
in which there is a high degree of public responsibility for 
citizens’ social and economic security (Table III). The context 
in the Netherlands differed slightly, as the Dutch patients need 
to be insured to receive the same social benefits. 
Table III shows large similarities across the 4 countries in 
structures related to funding, criteria for admission and discharge, 
clinical setting, rehabilitation team, and patient and family in-
volvement (Items 2, 3, 4, 5, 7, 8 in Table III). For example, in all 
the countries there were few other criteria for referring patients 
to arthritis rehabilitation than a referral from a doctor inside or 
outside a hospital. Criteria for discharge were predetermined and 
set at admission in all the 3 scandinavian countries, whereas in 
the Netherlands this criterion was related to the achievement of 
goals. Furthermore, the inpatient and outpatient arthritis reha-
bilitation programmes were provided in rheumatology hospital 
departments in all the 4 European countries, whereas in Nor-
way arthritis rehabilitation was also provided in rehabilitation 
centres. Moreover, there were only minor variations in the type 
of health professions available within the teams, and all teams 
held interdisciplinary team meetings once a week with informal 
communication between the team members when needed. All 
study sites also had standardized structures for patient involve-
ment, whereas only one study cited in sweden had an explicit 
standardized structure for family involvement (an information 
meeting in one of the outpatient clinics). 
Differences concerned structures of rehabilitation manage-
ment, length of team rehabilitation, and follow-up (items 7, 9, 
10 in Table III). Only the Dutch team provided a standardized 
tool for rehabilitation management in addition to an individual 
rehabilitation plan, which all the study sites included. Further-
more, the outpatient clinics in the Netherlands and sweden 
had a structure for routine follow-up management of ordinary 
patients at their department, whereas the inpatient clinics 
did not. Finally, there were large differences in the length of 
arthritis rehabilitation, varying from a 5-day course at one of 
the outpatient clinics in sweden up to a median of 21 work-
ing days at one of the inpatient clinics and the rehabilitation 
centres in Norway. 
Table II. Sociodemographic and health characteristics of patients (total n = 731)
Denmark
n = 91
The Netherlands
n = 80
Norway
n = 149
sweden
n = 411
Age, years, mean (sD) 59 (13) 53 (15) 53 (12) 54 (14)
Gender; women, n (%) 64 (70) 44 (55) 102 (69) 281 (68)
Marital status, living alone, n (%) 37 (41) 19 (24) 43 (29) 116 (29)
Work status, employed, n (%) 21 (23) 33 (41) 52 (35) 150 (38)
primary diagnosis
Rheumatoid arthritis 74 (81) 49 (61) 67 (45) 427 (58)
spondyloarthritis 17 (19) 31 (39) 173 (42) 303 (42)
Biologics at admission, n (%) 16 (19) 20 (25) 23 (15) 91 (26)
DMARDs at admission, n (%) 67 (78) 46 (58) 45 (30) 255 (68)
Corticosteroids at admission, n (%) 23 (27) 19 (24) 38 (26) 103 (29)
Use of analgesics at admission, n (%) 70 (81) 53 (66) 59 (44) 166 (57)
Functional status (hAQ2), mean (sD) 1.04 (0.69) 1.24 (0.67) 0.71 (0.51) 0.93 (0.59)
DMARDs: disease-modifying anti-rheumatic drugs; hAQ: health Assessment Questionnaire, scored from 0 = best possible score to 3 = worst possible; 
sD: standard deviation.
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Table III. Context and structure components of arthritis rehabilitation
study site
Denmark
(n = 91)
site D1
The 
Netherlands 
(n = 80)
site Nl1
Norway 
(n = 149)
sweden 
(n = 411)
site N1 site N2 site N3 site N4 site N5 site s1 site s2 site s3
Context
1. Welfare and healthcare systems
public healthcare system with equal access to  
all healthcare services
× – × × × × × × × ×
Insurance system necessary to have access to 
healthcare services
– × – – – – – – – –
Structure 
2. Funding
Covered by the health and welfare systems × – × × × × × × × ×
Full coverage by insurance companies – × – – – – – – – –
3. Criteria for admission and discharge
Referred from medical doctors within or outside 
hospital
× × × × × × × × × ×
Discharge set at admission × – × × × × × × × ×
Discharge predetermined (fixed programme) – – – – – × – – × ×
Discharge dependent on goal achievement – × – – – – – – – –
4a. Clinical setting (level of care)
secondary level × × – × × × × × × ×
Tertiary level – – × – – – – – – –
4b. Clinical setting (type of setting)
hospital inpatient × – × × × – – × – –
hospital outpatient – × – – – × – – × ×
Rehabilitation centre – – – – – – × – – –
4c. Clinical setting (diagnosis)
Primary diagnosis inflammatory arthritis × × × × × × × × × ×
secondary diagnoses × × × × × × × × × ×
5a. Rehabilitation team (type of professions on 
department level)
Medical doctor (rheumatologist) × × × × × × × × × ×
physiotherapist × × × × × × × × × ×
Occupational therapist × × × × × × × × × ×
Nurse × × × × × × × – × ×
social worker × × × × × × × × × ×
psychologist – – × – – – – – – –
Nutritionist × – – – – – – – – –
Other × – × × × – × – × ×
5b. Rehabilitation team (communication form)
Weekly team meetings × × × × × × × × × ×
Other meetings when needed × × × × × × × × × ×
6. Rehabilitation management
Individual rehabilitation plan × × × × × × × × × ×
standardized tool – × – – – – – – – –
Electronic-based tool – × – – – – – – – –
7. patient involvement
patient participation in team meeting at 
admission/discharge 
× × × × × × × × × ×
patient participation in all team meetings – – – – – – – – – –
8. Family involvement
standard for family involvement – – – – – – – – × –
Family involvement based on indication × × × × × × × × – ×
9. length of rehabilitation 
Median days (min–max) 14  
(4–19)
21.5  
(5–88)
21 
(9–23)
11 
(8–12)
10.5 
(7–27)
10 
(10–11)
21 
(5–30)
16 
(7–41)
18 
(18–18)
5  
(5–5)
10. Follow-up
standard for follow-up management – × – – – – – – × ×
The details are presented as present (× = yes, provided) or not (– = no, not provided) or not actual according (na) to study sites in the 4 countries. The 
detailed results on which this table is based can be provided by contacting the authors of this paper.
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Process of arthritis rehabilitation 
Table IV shows that the process of describing goals and providing 
a standardized assessment at admission and discharge were similar 
across the 4 countries (items 11 and 12 in Table IV). All the study 
sites classified clinical findings according to the main components 
of the International Classification of Functioning, Disability and 
health (ICF) (16) as part of their routine practice, but only the 
Dutch team classified goals. Similar domains of body functions 
and activity/participation in the ICF were assessed before and 
after arthritis rehabilitation at all study sites (data not shown). 
In all the study sites most of the individual treatment ses-
sions were provided by physiotherapists (data not shown). 
Furthermore, a combination of individual and group sessions 
was usually delivered, except in two outpatient clinics (one in 
sweden and one in Norway) which delivered a standardized 
group programme (item 13 in Table IV). Although there were 
large overlaps in the type of health profession that provided 
individual and group treatment sessions, the number of sessions 
varied widely between the different study sites (Table IV). For 
example, the number of sessions with exercises, either in terms 
of individual and group sessions or as self-training during 
the rehabilitation period, also showed large variations across 
the sites after adjusting for rehabilitation length (Fig. 1). The 
duration per session varied from 15 to 60 min across the study 
Table IV. The process component of arthritis rehabilitation. The details are presented as present (× = yes, provided) or not (– = no, not provided) or 
not actual (na) according to study sites in the 4 countries 
study site
Denmark  
(n = 91)
site D1
The 
Netherlands  
(n = 80)
site Nl1
Norway  
(n = 149)
sweden  
(n = 411)
site N1 site N2 site N3 site N4 site N5 site s1 site s2 site s3
11. Goals 
Individual goals defined × × × × × × × × × ×
Developed together with team member(s) × × × × × × × × × ×
Goals classified according to the ICF – × – – – – – – – –
12. Assessment and evaluation 
standardized assessment at admission × × × × × × × × × ×
standardized assessment at discharge 
(evaluation) × × × × × × × × × ×
Use of the main components of the ICF × × × × × × × × × ×
13a. Individual treatment by health profession 
(on individual level)
Medical doctor × × × × × na × × × na
physiotherapist × × × × × na × × × na
Occupational therapist × × × × × na × × × na
Nurse × × × × × na × × – na
social worker × × × × × na × × × na
psychologist – – × – – na – – – na
Nutritionist × – – – – na – – – na
Other × – × × × na × × × na
13b. Group sessions
Group education × – × × × × × – × ×
Group exercise × × × × × × × × × ×
13c. Type of individual treatment modalities 
Information/counsellinga – – × × × na × × × na
Individual exercisesb × × × × × na × × × na
Electrotherapyc – – × – × na × × × na
Thermotherapyd – – × × × na × × × na
Acupuncture – – – – – na × × × na
“Hands-on”e – – × × × na × × × na
psychological treatment – – × – – na – – – na
ADl help by nursef × – × × × na × × na na
13d. self-training × – × × × × × × × na
13e. Interdisciplinary team meetings × × × × × × × × × ×
aIncludes the following main topic: pain, physical activity, coping, weight control/nutrition, joint protection, assistive tools, ADl at home, social 
network, leisure activities, economy, official services, home visit, work/education, individual plan, other consultations, contact family/relatives, contact 
official services, contact healthcare providers, external collaboration meeting, other external meetings.
bMobility, muscle strength, coordination, aerobic capacity, relaxation, ADl, other individual exercises.
cUltrasound, TENs, low-level laser therapy, short-wave therapy and pulsed electromagnetic energy, shock-wave therapy.
dheat and/or cold packs. 
eMassage, passive joint mobility/manipulation, stretching, acupressure/trigger point treatment, other soft-tissue techniques.
fhelp with ADl.
The detailed results on which this table is based can be provided by contacting the authors of this paper.
ADL: activities of daily living; TENS: transcutaneous electrical nerve stimulation; ICF: International Classification of Functioning, Disability and Health.
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sites. Furthermore, the number of formal interdisciplinary team 
meetings varied from 1 meeting during the whole period up to 
a mean of 4.7 meetings. The number of interdisciplinary team 
meetings was highest in the Dutch team. In general, differ-
ences in type and frequency of treatment modalities included 
in arthritis rehabilitation were more evident across study sites 
than across countries.
DIsCUssION
This study explored different aspects of arthritis rehabilitation 
across 4 European countries using the sTAR-ETIC framework. 
The findings revealed large similarities across the countries in 
the current practice of arthritis rehabilitation with respect to: 
(i) the lack of a structure for admission and discharge except 
being referred from medical doctors within or outside hospital 
criteria; (ii) similar structures for the rehabilitation teams in-
cluding medical doctor, physiotherapist, occupational therapist, 
and social worker as the most common team members; (iii) 
emphasizing patient involvement as all patients participated in 
at least one team meeting at admission; (iv) a similar process 
of developing and defining individual goals; (v) a standard-
ized assessment at admission and discharge, in which the main 
components of the ICF (body function and structure, activity, 
participation, contextual factors) were used as a tool to guide 
this process; and (vi) the inclusion of group exercises in the 
intervention. There were also similarities in the context and 
structures for funding, clinical setting, rehabilitation manage-
ment, family involvement, and follow-up management. The 
finding that all 4 included countries had many similarities 
with respect to context and several structural and process 
factors, are promising with respect to comparing aspects of 
arthritis rehabilitation across our countries and study sites. 
These findings also underline topics that should be further 
improved, for example the fact that none of the countries had 
clear criteria for admission other than referral from a doctor, 
that most of the teams did not have a standardized structure 
for rehabilitation management, and that most teams lacked a 
structure for follow-up management. These findings are of 
clinical importance as they show a discrepancy between what 
is emphasized theoretically in the framework and in current 
practice. These topics deserve more attention from clinicians 
and researchers in collaboration.
The most evident differences in the content of arthritis re-
habilitation concerned the length of the rehabilitation period 
and the report of type and dosage of treatment modalities 
involved in arthritis rehabilitation. The differences in length 
of rehabilitation are important to consider when comparing 
outcomes of the different arthritis rehabilitation programmes, 
especially with respect to health economics outcomes (17). 
Although there was some overlap in many of the available 
treatment modalities, this study revealed large discrepancies 
in both type and dosage of in particular individual treatment 
modalities. 
The report of type and dosage of treatment modalities have 
been a key issue for the CONsORT recommendations (8, 9) 
in order to enable replication of complex interventions such as 
arthritis rehabilitation across studies. Even if the CONsORT 
for non-pharmacological treatments recommends that the inter-
ventions in trials should report details of the interventions “suf-
ficient to replication”, the recommendations are very general, 
thereby leaving it up to the researchers to decide the details of 
this critical information. A greater specificity of interventions 
has later been requested by both the CONsORT extension (9) 
and the TREND statement (10). They ask for full descriptions 
of treatment with any procedures used described, for example 
Fig.1. Different modes of exercises in arthritis rehabilitation across the 10 study sites in the four European countries (D1 = 1 site in Denmark, Nl1 = 
1 site in the Netherlands, N1–5 = 5 sites in Norway, s1-3 = 3 sites in sweden). All estimates are in mean number of sessions, adjusted for length of 
rehabilitation (number of working days).
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the timing of treatment, including duration and intervals of dos-
ing or sessions, any materials needed (such as patient handouts 
or devices), and accessibility of any materials or instructions, 
including overcoming language barriers (5). Due to the mul-
tiple health professions involved in arthritis rehabilitation this 
is a resource-demanding task. The two previous initiatives 
within the arthritis field, the Canadian framework for reporting 
health service models for managing RA (11) and the quality 
measure of the process of care in RA (12), also provide relevant 
information for describing arthritis rehabilitation. however, 
they do not provide enough information to allow replication 
of arthritis interventions; for example, with respect to type and 
dosage for each of the treatment modalities involved in arthritis 
rehabilitation. If this critical information is not systematically 
recorded and reported the variations may be too large to allow 
for valid research comparisons and/or syntheses. The large 
variation in the reporting of type and frequency of treatment 
modalities involved in this study clearly shows that, without a 
standard and transparent way to report these details, it is dif-
ficult to compare arthritis rehabilitation interventions across 
different units, studies or countries. In addition, replication 
of the interventions in research studies would be impossible.
Another important topic to consider for both clinicians and 
researchers is the level of evidence for the delivered treatment 
modalities in arthritis rehabilitation. Overall, there is much 
empirical evidence that exercise therapy can decrease pain 
and improve physical functioning in patients with arthritis. 
For example, in a Cochrane Review of dynamic exercises for 
RA, Hurkmans et al. (18) identified a total of 8 randomized, 
controlled trials with evidence that short-term aerobic capac-
ity and muscle strength training can provide a positive effect 
of exercises on functional ability and pain. similarly, when 
comparing home exercises with no intervention (1 trial/155 
patients) Dagfinrud et al. (19) found a significant positive 
effect of exercise on pain for patients with anky losing spon-
dylitis and a non-significant effect on function. Furthermore, 
a previous umbrella overview summarized evidence from 28 
systematic reviews on the effect of non-pharmacological and 
non-surgical interventions for RA (20), of which many of the 
interventions overlap with treatment modalities provided in the 
present study. High-quality evidence was found for beneficial 
effects of joint protection and patient education, which was a 
treatment modality that was delivered frequently in the present 
study. They also found moderate quality evidence for benefi-
cial effects of low-level laser therapy, which was delivered at 
approximately half of the present study sites. Importantly, the 
quality of evidence for the effectiveness of most non-phar-
macological therapy in RA was found to be moderate to low, 
also for treatment modalities that are delivered frequently in 
arthritis rehabilitation; for example, acupuncture, “hands-on” 
interventions, such as massage, passive joint mobility/manipu-
lation, stretching, acupressure or trigger-point treatment. This 
shows the need for more high-quality research on the different 
treatment modalities within arthritis rehabilitation.
There are limitations to this study. First, the sTAR-ETIC 
framework and checklist need to be tested for validity in gen-
eral, as well as feasibility in countries other than the 4 European 
countries involved. A critical aspect of a future validation is 
to ensure that all the information collected by the framework 
is representative for the arthritis rehabilitation provided at the 
study site, and not biased by the contribution or representation 
of any of the health professionals involved in the arthritis team. 
secondly, process data were provided by both health profes-
sionals and patients. These do not necessarily always agree. A 
reliability study of agreement between patients and healthcare 
providers should therefore be part of a validation study of the 
checklist. Thirdly, this study concerned patients with different 
inflammatory joint diagnoses. Even if it is likely that most of 
the structure and process components are similar across these 
diagnoses, we cannot rule out minor variations. For example, 
the delivery of exercises might be more frequent in sA patients 
compared with RA. Also, one of the sites included only RA 
patients, and hence, is not representative for patients with sA 
and psA. some of the differences between the countries and 
sites could also be due the difference in the samples included 
at each site. Fourthly, another source of variation might be the 
different professionals who were included at the study sites and 
the differences in the composition of the team care programme 
among the study sites. This issue illustrates the complexity of 
multidisciplinary rehabilitation and must be taken into account 
when interpreting the results from the current study. lastly, the 
administrative routine in data collection (e.g. using a research 
coordinator) could have been calibrated more strictly across 
the countries in order to reduce some of the variation in results. 
There are also advantages with this study. By using the 
sTAR-ETIC framework and checklist we were able to provide 
a detailed and transparent report of arthritis rehabilitation, both 
with respect to context, structural and process components. The 
checklist was based on the theoretical sTAR-ETIC framework 
for describing different aspects of rehabilitation care, includ-
ing definitions and conceptualizations of core elements in this 
health service. Although we realize that improvements and 
adaptations are needed before the sTAR-ETIC framework and 
checklist are implemented in clinical practice in particular, 
we suggest the use of this tool for clinicians and researchers 
who want to explore more systematically the “black box of 
multidisciplinary care” for patients with arthritis. A thorough 
and transparent description of the content of various arthritis 
rehabilitation interventions is also of crucial importance for 
patients and referring doctors. This can improve the basis for 
decision-making in clinical practice. A thorough description 
of arthritis rehabilitation should be provided when there is a 
particular need for it, either for research or clinical purposes. 
The variations in report of the content of treatment modali-
ties in the present data underline the need for further work 
regarding improving the report of type and dosage of various 
treatment modalities within arthritis rehabilitation. 
The content of current practice of arthritis rehabilitation was 
described and compared across 4 north European countries by 
using the STAR-ETIC framework and its checklist. The find-
ings of this study suggest that there are large similarities in the 
content of such practice across the countries in several of the 
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structure and process variables as well as in context. The most 
evident differences concerned the length of the rehabilitation 
period and the report of type and dosage of individual treatment 
modalities involved in arthritis rehabilitation. 
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